Elon Musk founded a brain chip company called Neuralink that has now been approved to commence its first clinical trial in Canada. Such a trial aspires to assist paralyzed individuals when controlling digital devices to use their thoughts.
The study focuses on safety and basic functionality evaluations of the Neuralink’s implant. This specifically targets individuals suffering from quadriplegia, which is a condition where all four limbs of a person are paralyzed. The device converts brain signals to digital commands, allowing users to interact with external gadgets like mobile phones and computers.
